LeapFrog backs Marengo hospitals with $42M to double bed capacity
What's the deal? LeapFrog InvestmentsDealroom has a profile for this one. Try Dealroom → has invested about 4 billion INR ($42 million) in Marengo Asia HospitalsDealroom has a profile for this one. Try Dealroom →, an Indian multi-specialty hospital platform, in a growth equity round. The capital comes from LeapFrog's fourth fund and will fund expansion across India's Tier-I and Tier-II cities.
What's the endgame? Marengo, established in 2021, operates five hospitals in India and has a strategic partnership in Saudi Arabia, together spanning about 2,000 beds and serving more than 900,000 patients a year. It aims to double capacity to 4,000 beds within two years.
Why now? LeapFrog frames India as a supply-starved market, citing 1.6 to 1.7 hospital beds per 1,000 people. "The demand-supply mismatch is massive," said Biju Mohandas, partner and global lead for healthcare at LeapFrog.
The firm points to urbanisation, rising incomes, insurance penetration, and growing demand for chronic care as underpinning the thesis.
Who else is involved? Marengo is backed by Samara CapitalDealroom has a profile for this one. Try Dealroom →, which holds a controlling stake, alongside Havells IndiaDealroom has a profile for this one. Try Dealroom → and the Godrej family officeDealroom has a profile for this one. Try Dealroom →. Avendus CapitalDealroom has a profile for this one. Try Dealroom → advised on the transaction; the parties declined to disclose the valuation.
Proceeds will fund both consolidation and new markets. "The proceeds will be used to consolidate our leadership in our existing markets while enabling us to expand into new geographies," said Abhishek Kabra, managing director of Samara Capital and chairman of Marengo Asia Hospitals.
The signal: The deal extends a run of healthcare bets from LeapFrog's Fund IV, which has recently backed Global Care Medical Center in the Philippines and pharmacy chain Pharmacity in Vietnam. It signals continued investor appetite for building hospital infrastructure across emerging Asian markets where bed shortages remain acute.
Read more: dealstreetasia.com
Image credit: tahitianlime
